Farida Murtiani

Farida Murtiani

Auto-generated profile, based on publicly available information

Farida Murtiani

Doctoral Program of Epidemiology, Faculty of Public Health, Universitas Indonesia, Indonesia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2021 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
RMRosa Marlina
Rosa Marlina
MHMochammad Hatta
Mochammad Hatta
ESEva Sridiana
Eva Sridiana
IDIrawaty Djaharuddin
Irawaty Djaharuddin
IPIlhamjaya Patellongi
Ilhamjaya Patellongi
FMFarida Murtiani
Farida Murtiani
Tuberculosis (TB) is still a major global health problem. The increasing prevalence of antibiotic resistance has posed a major threat towards the mission of TB eradication. Traditional medication has been a staple alternative and adjuvant to conventional treatment for Indonesians. Miana leaves (Coleus scutellariodes) is one such traditional medicine that has a potential role as immunoregulator, antiinflammation, and antimicrobial agent. Several studies have shown that Miana leaves extract can regulate TLR 4, the number of CD4 T cells, IFN-γ levels, and TNF-α.Vascular Endothelial Growth Factor (VEGF) mediates angiogenesis and vasodilatation to provide oxygenation and access for immune cells in hypoxic and inflamed site sue to infection focus. This study aims to study the effect of Miana leaves on VEGF expression. Balb/c mice were infected with Mycobacterium tuberculosis and were treated using Miana leaves extract, rifampicin, and rifampicin plus Miana. VEGF protein levels before infection, after infection, and after treatment were measured using ELISA. The results showed that there was a significant difference in VEGF level means between treatment groups. VEGF levels in rifampicin, Miana, and rifampicin plus Miana groups were significantly lower than placebo. VEGF level was significantly lower in rifampicin group compared to Miana group. VEGF level was significantly lower in rifampicin plus Miana group compared to Miana group. There was no significant difference of VEGF level between rifampicin and rifampicin plus Miana group. The results indicate that Maina leaves does have an effect on VEGF level in mice infection with Mycobacterium tuberculosis.

31 March 2022 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
RRRosamarlina Rosamarlina
Rosamarlina Rosamarlina
MHMochammad Hatta
Mochammad Hatta
IDIrawaty Djaharuddin
Irawaty Djaharuddin
IPIlhamjaya Patellongi
Ilhamjaya Patellongi
ASAgus Dwi Susanto
Agus Dwi Susanto
SPSesilia Rante Pakadang
Sesilia Rante Pakadang
Background: Increasing resistance to TB drugs raises the challenge of TB eradication. Miana leaves is Indonesian traditional herbal medicine, have antimicrobial, anti-inflammatory, and immunoregulatory action. Not much is known about the effect of Miana on HIF-1α and ICAM-1, the immunoregulators of infection and inflammation. This study aims to elucidate the effect of Miana on HIF-1α and ICAM-1 in M. tuberculosis (Mtb) infected mice. Materials and Methods: This experimental study used Mtb infected Balb/c mice were divided into 4 groups; group 1 is placebo, group 2 is treated with Rifampicin as Anti TB drug, group 3 is treated with Miana, and group 4 is treated with Miana + Anti TB drug. HIF-1α and ICAM-1 serum levels were analyzed using ELISA. Results: There is a significant difference of mean HIF-1α (p= 0.00, F = 114.21) and ICAM-1 (p= 0.00, F = 113.11) between the four groups after treatment. HIF-1α level is significantly lower in anti TB treatment, Miana, and Miana + anti TB treatment compared to placebo (mean difference (MD) 35,764.67, p=0.00; 29,230.98, p=0.000; 38,489.62, p=0.00, respectively). Furthermore, ICAM-1 level is significantly lower in anti TB treatment, Miana, and Miana + anti TB treatment compared to placebo (MD 95,449.68, p=0.00; 79,509.69, p=0.00; 108,672.83, p=0.00, respectively). Conclusion: HIF-1α and ICAM-1 expression was reduced after Miana administration. Miana can be a potential complement to anti-TB treatment but cannot replace rifampicin as anti-TB drugs.

31 March 2025 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
URUpik Rahmi
Upik Rahmi
HGHanna Goenawan
Hanna Goenawan
NSNova Sylviana
Nova Sylviana
ISIwan Setiawan
Iwan Setiawan
SPSuci Tuty Putri
Suci Tuty Putri
FMFarida Murtiani
Farida Murtiani
The hippocampus is essential for learning and memory, with the p53 protein serving as a critical regulator of these cognitive processes. While p53 is predominantly recognized for its role in apoptosis, it also plays a vital role in modulating synaptic plasticity and preserving hippocampal health. This review explores the influence of p53 on synaptic function and long-term potentiation (LTP) in CA1 neurons, emphasizing its neuroprotective properties within the central nervous system. A comprehensive literature search was conducted across databases such as PubMed and ScienceDirect, employing systematic inclusion and exclusion criteria. We limited our analysis to experimental studies published in English between 2001 and 2022, specifically including articles that were not systematic reviews or literature articles, and excluding animal studies, simplified abstracts, and book chapters. A total of six articles were deliberately chosen for review, examining varied patterns of p53 and synaptic function in diverse contextual settings. The findings reveal that p53 gene regulation is integral to neuronal transcription and is influenced by synaptic activity, with LTP induction correlating with increased p53 transcription levels. Furthermore, miR-34c enhances synaptic function by promoting the expression of synaptotagmin 1. Under apoptotic conditions, p53 is localized at synaptic terminals, contributing to mitochondrial dysfunction and oxidative stress, which leads to synaptic mitochondrial depolarization. The activation of p53 in the CA1 region highlights its dual role in facilitating apoptosis while also providing neuroprotection. These findings suggest that targeting p53 pathways may offer novel therapeutic strategies for enhancing synaptic function and protecting against neurodegenerative diseases, emphasizing the need for a balanced approach to modulate its activity for optimal neuronal health.

21 April 2025 in Narra J
Verified
Journal Article
Open access
PDF file
SMSiti Maemun
Siti Maemun
AWAninda D. Widiantari
Aninda D. Widiantari
FMFarida Murtiani
Farida Murtiani
HHHerlina Herlina
Herlina Herlina
DTDian W. Tanjungsari
Dian W. Tanjungsari
TPTri Bayu Purnama
Tri Bayu Purnama
The high transmissibility and mortality rates of the COVID-19 pandemic pose significant challenges. Patients can deteriorate rapidly, making it crucial to identify laboratory biomarkers for high-risk individuals. The aim of this study was to evaluate the predictive value of various laboratory parameters, including C-reactive protein (CRP), D-dimer, ferritin, neutrophil-to-lymphocyte ratio (NLR), prothrombin time (PT), and procalcitonin (PCT), in predicting COVID-19 mortality. A retrospective cohort study was conducted at Sulianti Saroso Infectious Disease Hospital, where COVID-19 patients were categorized into survivors and non-survivors. The Mann-Whitney test was used to assess group differences, while receiver operating characteristic (ROC) curve analysis was performed to evaluate the predictive performance of each biomarker, with Youden's index (J) determining optimal cut-off values. Kaplan-Meier analysis was used to compare median survival times, and Cox regression assessed hazard rates and the relationship between biomarkers and mortality. A total of 1,598 patients were analyzed, the majority of whom were admitted with oxygen saturation levels >95% and classified as having mild to moderate disease severity. Among them, 216 patients died, resulting in a mortality rate of 13.52%. Significant variations in mortality rates were observed along the survival functions for NLR, ferritin, D-dimer, CRP, and PCT (p<0.001). The survival curves for these biomarkers demonstrated distinct trends across tertiles over time. Among hematological markers, NLR was significantly associated with mortality (p<0.001), with a 1.5–2.2% increased risk per unit increase. Biochemical markers (complete blood count) proved to be more effective than hematological parameters (NLR, ferritin, PT, D-dimer, CRP, PCT) when evaluating individual prognostic performance. Bivariate analysis of CRP, D-dimer, ferritin, NLR, PT, and PCT between survivors and non-survivors showed significant differences. Notably, NLR and PCT were highly relevant for predicting disease prognosis and mortality, with sensitivity and specificity values exceeding 80%.

25 August 2023 in Global Medical & Health Communication (GMHC)
Verified
Journal Article
Open access
RRRosamarlina Rosamarlina
Rosamarlina Rosamarlina
NMNina Mariana
Nina Mariana
TSTiti Sundari
Titi Sundari
TSTri Yuli Setianingsih
Tri Yuli Setianingsih
JJJahiroh Jahiroh
Jahiroh Jahiroh
FMFarida Murtiani
Farida Murtiani
Global Medical and Health Communication

30 August 2025 in Public Health of Indonesia
Verified
Journal Article
Open access
PDF file
FMFarida Murtiani
Farida Murtiani
RRRosamarlina Rosamarlina
Rosamarlina Rosamarlina
APAsep Purnama
Asep Purnama
NFNur Farhanah
Nur Farhanah
MUMade Susila Utama
Made Susila Utama
AHArmedy Ronny Hasugian
Armedy Ronny Hasugian
Background: Screening tests are needed to help screen suspected Tuberculosis (TB) pulmonary with HIV positive. With the limitation of specificity of the screening test and the need for combination with laboratory tools to increase that, a combination with standard examination is still needed, especially for limited healthcare facilities. Objective: This study aimed to determine Pulmonary TB screening tests with Human Immunodeficiency Syndrome (HIV) positive. Method: This observational study with a cross-sectional design was conducted in four government hospitals. Study subjects were inpatients and outpatients who met study inclusion criteria (> 14 years of age, HIV positive based on HIV test results, had clinical symptoms of episodic history of fever, and volunteered to take part in the study). Total subjects were 193 people, with episodic history of fever from 85%. Still, only the complete combination has a specificity of> 70%. The combination of “Night Sweat + Enlargement of Lymph Nodes + Left Rhonchi + Infiltrates in the Upper Lobe” and then “Enlargement of Lymph Nodes + Left Rhonchi + Infiltrates in the Upper Lobe” can be an alternative for screening Pulmonary TB-HIV positive with history of fever. Conclusion: Pulmonary TB screening in HIV patients with a history of fever can be used by completely combining clinical manifestation, physical examination, and X-ray. the variables "Night Sweat, Enlarged Lymph Nodes, left rhonchi breath sounds and pulmonary upper lobe infiltrates" in a gradual manner. Keywords: Diagnostic Combination Test; HIV-Tb Coinfection; Tuberculosis Screening; Clinical Manifestations in TB-HIV; Pulmonary TB in HIV Patients